|

PTX-100 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Prescient Therapeutics, Ltd.1

Indications

  • CTCL1
  • Cancer1

Duarte, California1 trial

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

City of Hope Comprehensive Cancer Cente

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.